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Abbreviations 
When applicable, the notation refers to mouse genes. In line with the 
International Committee on Standardized Genetic Nomenclature for Mice 
(Eppig, et al., 2007), gene symbols are italicized and begin with an uppercase 
letter, followed by lowercase letters, whereas protein symbols use all uppercase 
letters, and are not italicized. 
 
Acaca  Acetyl-Coenzyme A carboxylase  
Actb  actin  
AMPK AMP-activated protein kinase 
ANOVA Analysis of variance 
ASPS  Advanced Sleep Phase Syndrome 
B2M  -2 microglobulin 
Bmal1  Brain and muscle aryl hydrocarbon receptor nuclear translocator 
  like 1 (Arntl) 
C6  Rat glioma cell line 
cDNA  complementary DNA 
Clock  Circadian locomotor output cycles kaput 
Cry1  Cryptochrome 1 
Cry2  Cryptochrome 2 
Csnk1 Casein kinase 1,  (Ck1) 
Dbp  D site albumin promoter binding protein 
DMSO Dimethyl sulfoxide 
DSPD  Delayed Sleep Phase Disorder 
E4bp4  E4 promoter binding protein 4 (Nfil-3) 
Fads2  Fatty acid desaturase 2 
Fasn  Fatty acid synthase 
FASPS Familial Advanced Sleep Phase Syndrome 
GABA -aminobutyric acid 
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GaMg  Human glioma cell line 
Gapdh Glyceraldehyde 3-phosphate dehydrogenase 
GRP  Gastrin-releasing peptide 
Gsk-3 Glycogen synthase kinase 3 
GWAS Genome-wide association study 
H-35  Rat hepatoma cell line (Reuber's) 
HepG2 Human hepatoma cell line 
HK-2  Human kidney cell line 
Hlf  Hepatic leukemia factor 
Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase 
MEQ  Horne-Östberg Morningness Eveningness Questionnaire 
mRNA messenger RNA 
Mvk  Mevalonate kinase 
NIH-3T3 Mouse embryonic fibroblast cell line 
NKA  Na+/K+-ATPase 
Nthy-ori 3-1 Human thyroid cell line 
PACAP Pituitary adenylate cyclase-activating polypeptide 
Per1  Period homolog 1 (Drosophila) 
Per2  Period homolog 2 (Drosophila) 
Per3  Period homolog 3 (Drosophila) 
Pgc-1 Peroxisome proliferator activated receptor  coactivator  
  1 (Ppargc1) 
Ppar- Peroxisome proliferator activated receptor  
Ppar- Peroxisome proliferator activated receptor  
PS  Preferences Scale 
qRT-PCR Quantitative real-time polymerase chain reaction 
Rev-Erb- Reverse viral erythroblastis oncogene product  (Nr1d1) 
RHT  Retinohypothalamic tract 
Ror-  Retinoic acid-related orphan receptor  
RORE  Retinoic acid-related orphan receptor response element 
Rplp0  Ribosomal protein, large, P0 
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Scd1  Stearoyl-Coenzyme A desaturase 1 
Scd2  Stearoyl-Coenzyme A desaturase 2 
SCN  Suprachiasmatic nucleus 
shRNA Small hairpin RNA 
SNP  Single-nucleotide polymorphism 
SREBP Sterol regulatory element-binding protein 
SSRI  Selective serotonin reuptake inhibitor 
Tef  Thyrotroph embryonic factor 
VIP  Vasoactive intestinal peptide 
VNTR Variable number tandem repeat 
VP  Vasopressin  
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Summary 
The sleep-wake cycle, lipid metabolism and hormone levels are examples of 
circadian rhythms, which are endogenously generated cycles that reach both 
maximum and minimum values once in the course of 24 hours. In mammals, 
circadian rhythms are regulated by a set of clock genes that are functionally 
linked, and polymorphisms in these genes may be associated with variations in 
circadian rhythms. Disruption of the circadian clock has been associated with 
poor physical health, including metabolic disturbances such as obesity and 
dyslipidemia, as well as mental illness, including bipolar disorder, a severe 
chronic affective disorder. The mood stabilizer lithium is widely used in the 
pharmacological treatment of bipolar disorder, and has been shown to affect 
circadian rhythms, although its molecular mechanisms of action remain largely 
unknown. 
 
In this study, we investigated cultured mice fibroblasts (NIH-3T3 cells) for 
effects of lithium on the expression of genes that regulate the circadian clock. 
Robust circadian oscillations of rhythmic clock genes were observed in control 
and lithium-treated samples in this model of the circadian clock. A main effect 
of lithium was to differentially alter the amplitude of expression of several 
clock genes, including an increase in the peak amplitude of Per2 and Cry1, and 
a reduction of the maximal amplitude of Per3, Bmal1 and Rev-Erb- 
transcription, indicating a possible role for alteration of oscillation amplitudes 
of clock genes in the mechanisms of lithium action on biological rhythms. 
Additional mood stabilizers, antipsychotics and antidepressants are also used in 
the treatment of bipolar disorder; hence we investigated whether they too affect 
the transcription of key circadian clock genes. Interestingly, clock gene 
expression was differentially up- or down-regulated, such as a reduction of 
Per2 transcription by clozapine and imipramine, and an increase in the 
expression of Rev-Erb- by clozapine. The observed drug-induced effects 
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could reflect shared regulatory mechanisms that contribute to their 
psychotropic action. Since numerous antipsychotics and antidepressants are 
known to induce lipogenic gene expression, and given the suggested link 
between the circadian clock and lipid metabolism, we also examined their 
effects on lipid metabolism-related genes. The antipsychotics and 
antidepressants increased the transcription levels of lipid metabolism genes 
(which did not oscillate), whereas the mood stabilizers had no such effect, 
indicating that no evident regulatory link between the circadian clock and lipid 
metabolism is present in this model system, although it cannot be excluded. 
 
Genetic factors are likely to influence diurnal preference (chronotype), and in 
search of associations between clock gene variants and chronotype, several 
studies have investigated the role of the clock gene PER3, and found an 
association between a variable number tandem repeat (VNTR) in PER3 and 
diurnal preference. However, conflicting findings have been reported, and our 
replication study on 432 healthy Norwegian students did not confirm the 
association, indicating that variation in the PER3 VNTR does not appear to be 
associated with self-report measures of chronotype in our study sample, and 
suggesting that further studies are needed to clarify the proposed role of PER3. 
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It is not the strongest of the species that survives, nor the most 
intelligent that survives. It is the one that is the most adaptable 
to change. 
 
 
Charles Darwin 
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1  Introduction 
1.1 Circadian rhythms and physiological processes 
Rotation of the earth around its axis creates a repetitive cycle of day and night. 
Most living organisms, spanning from humans and animals to plants, fungi and 
bacteria, anticipate the daily changes in their environment by having circadian 
rhythms, which reflects the strong pressure in natural selection in favoring 
organisms with a built-in clock. The circadian clock is evolutionary conserved 
and is estimated to be around 700 million years old, originating from the time 
when plants diverged from the common lineage with animals and fungi (for 
review, see Dunlap, 1999; Lowrey and Takahashi, 2004; von Schantz, 2008). 
In comparison, Homo sapiens emerged only 200,000 years ago. 
 
The circadian clock is a cellular mechanism that generates rhythmic output, 
with temporal organization, allowing biological processes to occur at the most 
opportune time, while preventing incompatible reactions from taking place 
simultaneously (reviewed by Gachon, et al., 2004). The term circadian derives 
from the Latin circa diem, meaning “about one day”, which is roughly the 
period length of circadian rhythms. Examples of physiological parameters that 
display circadian rhythms include the sleep-wake cycle, feeding behavior, core 
body temperature, hormone levels, blood pressure and metabolism (for reviews 
on circadian rhythms, see Dardente and Cermakian, 2007; Takahashi, et al., 
2008; Hastings, et al., 2008). The human circadian rhythms of core body 
temperature, physical activity and cognitive functions all peak in the afternoon, 
while in contrast triglyceride levels and secretion of the hormone melatonin 
both peak during the subjective night (Redman, et al., 1983; Rajaratnam and 
Arendt, 2001), see Figure 1.1. 
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Figure 1.1. Circadian rhythms of melatonin, triglycerides, core body temperature and 
subjective alertness in human beings. Plasma melatonin and triglyceride levels peak during 
the night. They have similar phases and oscillate in antiphase with core body temperature and 
alertness levels, which reach their minimum values (troughs) at night. The parameters were 
measured in humans kept in controlled conditions, and are given as functions of circadian 
time (in hours). Plasma melatonin level is given in pg/mL, plasma triglycerides in mmol/L, 
body temperature in degrees Celsius and alertness was estimated with a subjective scale (0 = 
not alert and 100 = very alert). Illustration modified from Rajaratnam and Arendt and 
reproduced with permission of the authors (Rajaratnam and Arendt, 2001). 
 
Circadian oscillations are characterized by their period, amplitude and phase. 
The rhythms are endogenously generated, but may be entrained by external 
time cues (Zeitgebers). The most important cue is light, although feeding time 
and ambient temperature may also set the clock (Damiola, et al., 2000; 
Stokkan, et al., 2001; reviewed in Gachon, et al., 2004). Circadian rhythms are 
still existent in the absence of external Zeitgebers and remain invariant within a 
physiological range of temperatures (temperature compensation), even in cell 
culture (Tsuchiya, et al., 2003; Izumo, et al., 2003). 
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1.2 The mammalian circadian pacemaker and peripheral 
clocks 
Since the endogenous period commonly deviates slightly from 24 hours, the 
clock needs continuous adjustment to the external 24-hour cycle. This takes 
place in the circadian pacemaker, which in mammals consists of a population 
of neurons in the suprachiasmatic nuclei (SCN) of the brain. The SCN are 
bilateral structures located in the anterior hypothalamus, situated just above the 
optic chiasm, which in mice consist of around 10,000 neurons each 
(Abrahamson and Moore, 2001). It was demonstrated that bilateral ablation of 
the SCN in rats permanently destroyed their circadian rhythms (Figure 1.2A) 
(Stephan and Zucker, 1972; Moore and Eichler, 1972) and it was later shown 
that surgically implanting intact SCNs in hamsters restored rhythmicity 
(Lehman, et al., 1987). Moreover, functional SCN transplants in genetically 
arrhythmic mice generated a circadian rhythm with a period similar to that of 
the donor animal, and not the host (Ralph, et al., 1990; Sujino, et al., 2003). 
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Figure 1.2A. Ablation of the SCN causes loss of circadian rhythms. The locomotor 
activity recording of a rat kept in a light-dark cycle is depicted on horizontal lines, with two 
days per line. Locomotor activity displays a circadian pattern of activity (black bars) and rest 
(white bars). The data has been double-plotted to facilitate visualization, with each line 
showing the preceding day and the following day. Following bilateral SCN ablation (as 
indicated by the arrow), activity is randomly distributed, indicating loss of circadian rhythms. 
Modified from Moore (Moore, 1999). 
 
The circadian clock is characterized by three components: input pathways that 
reset the time, a pacemaker that generates the rhythm, and output signals that 
control circadian gene expression to promote circadian physiology and 
behavior (for review, see King and Takahashi, 2000; Lowrey and Takahashi, 
2004). Light is a powerful Zeitgeber, and entrainment of the SCN clock is 
achieved by means of light-sensitive neurons in the retina that project directly 
to the SCN via the retinohypothalamic tract (RHT) (Figure 1.2B) (Moore and 
Lenn, 1972; Sadun, et al., 1984). These retinal ganglion cells express the 
photopigment melanopsin (Gooley, et al., 2001; Hannibal, et al., 2002; Hattar, 
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et al., 2002; Hannibal, et al., 2004). Melanopsin transduces light, and electrical 
signals are sent through the RHT to the SCN where the neurons release the 
transmitters glutamate and pituitary adenylate cyclase-activating polypeptide 
(PACAP) (Hannibal, et al., 2000; reviewed in Reppert and Weaver, 2002; 
Hannibal, 2002), initiating a cascade of reactions that leads to adjustment of the 
circadian clock. 
 
 
 
Figure 1.2B. The retinohypothalamic tract. Light is a powerful Zeitgeber, and is 
transduced into neural signals by specific light-sensitive neurons in the retina of the eye. In 
turn, these retinal ganglion cells project directly to the SCN via the RHT, where they serve to 
entrain the SCN clock. Illustration by Osland TM, with the use of Servier Medical Art. 
 
Distinct cell populations in the SCN contribute to the clock, and based on their 
neurochemical properties they form two functional subregions, where a 
venterolateral core contains neurons expressing several neurotransmitters, 
including vasoactive intestinal peptide (VIP) and gastrin-releasing peptide 
(GRP), whereas a dorsomedial shell is characterized by neurons that express 
vasopressin (VP) (Abrahamson and Moore, 2001; reviewed in Moore, et al., 
2002; Hastings and Herzog, 2004). In addition, in most SCN neurons, the 
above-mentioned neuropeptides are colocalized with -aminobutyric acid 
(GABA) (Moore and Speh, 1993). To adjust the SCN clock by light, retinal 
input entrains the core neurons of the SCN, before the signal is conveyed from 
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the light-induced cells in the core to the rhythmic cells in the shell, which then 
set the clock (reviewed in Antle and Silver, 2005). 
 
Circadian rhythms are found throughout the body, including peripheral organs 
such as lungs, kidneys, liver and skin (Zylka, et al., 1998; Yamazaki, et al., 
2000; Bjarnason, et al., 2001; Yoo, et al., 2004). SCN neurons mainly project 
to neighboring areas in the hypothalamus, but also to the surrounding thalamus 
and other areas of the brain (Berk and Finkelstein, 1981; Abrahamson and 
Moore, 2001). Circadian output signals from the SCN are transmitted via 
neural connections (Ueyama, et al., 1999; la Fleur, et al., 2000; for review, see 
Kalsbeek, et al., 2006) and humoral pathways (Silver, et al., 1996; Oishi, et al., 
1998b; McNamara, et al., 2001) to synchronize local clocks in peripheral 
organs. The pacemaker is self-sustained, whereas the oscillation of peripheral 
clocks will dampen markedly after a few cycles without input from the SCN 
(Yamazaki, et al., 2000; reviewed in Hirota and Fukada, 2004). Circadian 
clocks consist of numerous, autonomous single cell oscillators that are 
synchronized to generate coordinated output (Welsh, et al., 1995), and certain 
cell cultures grown in vitro may also display circadian rhythms (Balsalobre, et 
al., 1998; Akashi and Nishida, 2000; Allen, et al., 2001). Although there is a 
delay of 4-6 hours in the expression patterns of circadian clock genes and 
proteins between the SCN and peripheral clocks (Lopez-Molina, et al., 1997; 
Balsalobre, et al., 1998; Zylka, et al., 1998; Allen, et al., 2001; reviewed in 
Balsalobre, 2002), the clock mechanisms are highly similar (reviewed in Ko 
and Takahashi, 2006), which allows us to use cell culturing as a model for 
peripheral circadian clocks. 
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1.3 Clock genes and molecular mechanisms of the 
mammalian circadian clock 
Clock genes encode proteins that are necessary for the generation or regulation 
of the circadian clock. Numerous clock genes have oscillating expression 
patterns, such as period homolog 1 (Per1), period homolog 2 (Per2), period 
homolog 3 (Per3), cryptochrome 1 (Cry1), cryptochrome 2 (Cry2) and brain 
and muscle aryl hydrocarbon receptor nuclear translocator like 1 (Bmal1) (Tei, 
et al., 1997; Balsalobre, et al., 1998; Oishi, et al., 1998a; Zylka, et al., 1998; 
Fustin, et al., 2009), whereas others are expressed at constant levels, including 
circadian locomotor output cycles kaput (Clock) (Oishi, et al., 1998a; 
Shearman, et al., 1999; Shearman, et al., 2000) (Figure 1.3A). Interestingly, 
mice with a clock gene mutation may have abnormal rhythms or may even be 
arrhythmic (Vitaterna, et al., 1994; Bae, et al., 2001; reviewed in King and 
Takahashi, 2000; Ko and Takahashi, 2006). 
  
  
20 
 
 
 
 
Figure 1.3A. Gene expression profiles of Per2, Bmal1 and Clock in cultured mouse 
fibroblasts (NIH-3T3) cells following a serum shock. NIH-3T3 cells were transiently 
exposed to a high dose (50%) of serum (serum shock) to synchronize circadian rhythms. 
After an initial surge of transcription, robust oscillations of Per2 (red symbols) and Bmal1 
(blue symbols) expression levels were observed, in antiphase with each other. In contrast, the 
expression of Clock (green symbols) did not oscillate. Cell cultures were serum-shocked at 
time t=0 and the mean value of n=3 replicates is given for each time point. The expression 
values were normalized to glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and the value 
at time t=0 was arbitrarily set to 1. Experiment performed by Osland TM. 
 
Clock genes are linked together by several positive and negative 
transcriptional-translational feedback loops, ensuring stable oscillations in the 
levels of both messenger RNAs (mRNAs) of clock genes and their protein 
levels. The causes and effects in the feedback loops are circularly linked, and 
include the proteins CLOCK and BMAL1, forming a heterodimer that binds to 
regulatory sequences (E-boxes) to activate the transcription of several other 
clock genes, including Per1, Per2, Per3, Cry1 and Cry2 (King, et al., 1997; 
Gekakis, et al., 1998; Jin, et al., 1999; Bunger, et al., 2000; reviewed in 
Reppert and Weaver, 2001). Following translation in the cytoplasm, PER and 
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CRY proteins dimerize and enter the nucleus, where the PER-CRY complex 
inhibits the actions of the CLOCK-BMAL1 dimer, thus indirectly repressing 
their own transcription via a negative feedback loop (Kume, et al., 1999; 
Vitaterna, et al., 1999; Griffin, et al., 1999; Shearman, et al., 2000) (Figure 
1.3B). Subsequently, PER and CRY proteins are degraded, and when their 
protein levels are sufficiently low, the cycle is complete and Per and Cry 
mRNA levels may rise again. Another feedback loop involves Bmal1 
transcription, which is positively regulated by retinoic acid-related orphan 
receptor- (Ror-) (Sato, et al., 2004), and negatively regulated by reverse 
viral erythroblastis oncogene product  (Rev-Erb-) (Preitner, et al., 2002), 
where the proteins REV-ERB- and ROR- compete to bind at retinoic acid-
related orphan receptor response elements (ROREs) in the promoter of Bmal1 
with opposite effects (Preitner, et al., 2002; Sato, et al., 2004; Guillaumond, et 
al., 2005). In turn, the transcription of both Ror- and Rev-Erb- is modified 
by the CLOCK-BMAL1 dimer (Preitner, et al., 2002; Sato, et al., 2004; 
reviewed in Ko and Takahashi, 2006). The interacting feedback loops 
contribute to tight regulation of the clockwork, necessary to maintain a period 
of close to 24 hours. Furthermore, post-translational mechanisms, including 
phosphorylation, dimerization, nuclear import and export, regulation of 
transcriptional activity and chromatin modification all participate in fine-tuning 
the oscillations and contribute to the precision of the clock (Lee, et al., 2001; 
reviewed in Ko and Takahashi, 2006; Dardente and Cermakian, 2007). As an 
example, phosphorylation of PER proteins by casein kinase 1,  (CSNK1) 
contributes to regulating protein stability (Vielhaber, et al., 2000; Lowrey, et 
al., 2000; Vanselow, et al., 2006). 
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Figure 1.3B. Gene expression and feedback mechanisms in the mammalian circadian 
clock. The expression of the mammalian clock genes Per, Cry, Rev-Erb-, Ror- and Bmal1 
is tightly regulated to ensure proper circadian oscillations. The CLOCK-BMAL1 complex 
drives a positive forward loop by binding to E-boxes and promoting transcription of target 
genes, whereas the heterodimer PER-CRY inhibits transcription mediated by CLOCK-
BMAL1. An additional feedback loop involves REV-ERB- and ROR-, that compete to 
bind to ROREs to regulate the expression of Bmal1 with opposite effects. Illustration by 
Fernø J and Osland TM (modified from Hirota and Fukada, 2004). 
 
The circadian clock regulates the expression of numerous target genes, 
including D site albumin binding protein (Dbp), hepatic leukemia factor (Hlf), 
thyrotroph embryonic factor (Tef) and E4 promoter binding protein 4 (E4bp4). 
These transcription factors exhibit circadian cycling in the SCN and peripheral 
tissues (Lopez-Molina, et al., 1997; Balsalobre, et al., 1998; Mitsui, et al., 
2001), and regulate downstream target genes involved in neurotransmitter 
metabolism and fatty acid metabolism (for review, see Staels, 2006). 
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Disruption of the circadian clock may have impact on many aspects of 
physiology and behavior, and has been associated with complications such as 
sleep disturbances, mental illness (including bipolar disorder), metabolic 
complications and cancer (for review, see Gachon, et al., 2004; Lamont, et al., 
2007). 
 
1.4 Diurnal preference and clock genes 
Diurnal preference (chronotype) indicates the preference of an individual for 
morning versus evening. Morning types tend to rise early and are energetic in 
the first part of the day, whereas evening types generally get up later and have 
a correspondingly delayed activity peak. There is large variation in chronotype 
between individuals, also among people living in the same environmental 
conditions (reviewed in Roenneberg, et al., 2007). These differences may be 
described by a scale of morningness-eveningness, as evaluated with standard 
questionnaires such as the Horne-Östberg Morningness Eveningness 
Questionnaire (MEQ, Horne and Ostberg, 1976) and the Preferences Scale (PS, 
Smith, et al., 2002). Circadian rhythm sleep disorders are found at the two 
extremities of the chronotype scale. Subjects with advanced sleep phase 
syndrome (ASPS) suffer from drowsiness in the late afternoon (or early 
evening) followed by persistent early onset of sleep and spontaneous early 
morning awakening, both occurring before the conventional or desired time 
(ICSD-2, American Academy of Sleep Medicine, 2005). Delayed Sleep Phase 
Disorder (DSPD) is found at the other extremity, with subjects typically having 
a stable sleep schedule, with onset of sleep later than preferred (often between 
2 a.m. and 6 a.m.) and great difficulty rising at the desired time in the morning 
(ICSD-2, American Academy of Sleep Medicine, 2005). 
 
Several clock genes have been examined for influence on diurnal preference, 
and an association between a single-nucleotide polymorphism (SNP) in the 
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clock gene CLOCK and chronotype has been found (Katzenberg, et al., 1998), 
but conflicting results have also been reported (Robilliard, et al., 2002; 
Pedrazzoli, et al., 2007). In addition, mutations in PER2 may lead to a heritable 
autosomal dominant subtype of ASPS known as Familial Advanced Sleep 
Phase Syndrome (FASPS) (Toh, et al., 2001). FASPS patients have advanced 
sleep-wake cycles, and their oscillations of core body temperature and 
melatonin are correspondingly advanced by 4-5 hours. Sequence variations of 
the human PER3 gene have been extensively studied for vulnerability to 
circadian rhythm traits, and a variable number tandem repeat polymorphism 
(VNTR) in exon 18 of PER3 was reported to be associated with DSPD 
(Ebisawa, et al., 2001). The VNTR exists as a short allele of 4 tandem repeats 
of 54 base pairs and a long allele of 5 such repeats. The authors found an 
association between DSPD and the short allele in a Japanese population. 
Several replication studies have since been performed in both DSPD patients 
and the general population, with diverging results (Archer, et al., 2003; Pereira, 
et al., 2005; Viola, et al., 2007), indicating a need for additional studies. 
 
1.5 The circadian clock, bipolar disorder and lithium 
1.5.1 Clinical aspects of bipolar disorder and circadian rhythms 
Bipolar disorder is a serious mental illness, characterized by extreme mood 
swings with alternating periods of mania and depression. It is thought that 
circadian rhythms may play a role in the pathophysiology, as irregular sleep 
patterns are commonly seen in bipolar patients (Wehr, et al., 1985; Kasper and 
Wehr, 1992; Klemfuss, 1992; reviewed in Manji and Lenox, 2000; Jackson, et 
al., 2003), and subjects may present with unstable cycling of other circadian 
parameters, e.g. body temperature, blood pressure and melatonin secretion 
(Atkinson, et al., 1975; Kripke, et al., 1978;  or see Lenox, et al., 2002; 
McClung, 2007 for reviews). 
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1.5.2 Clock genes and the heritability of bipolar disorder 
The lifetime risk of bipolar disorder is around 1% (Merikangas, et al., 2007). It 
is a potentially disabling condition with a significantly elevated suicide rate, 
which together with an increased occurrence of cardiovascular disease and 
metabolic disorders, leads to a mortality rate that is 2-3 times higher among 
patients than in the general population (Osby, et al., 2001; Laursen, et al., 
2007; reviewed in Muller-Oerlinghausen, et al., 2002; Fagiolini, et al., 2008). 
Both environmental and genetic factors are thought to be involved in the 
etiology of the condition, with a complex mode of inheritance (reviewed by 
Barnett and Smoller, 2009). Family studies have revealed a markedly higher 
prevalence of bipolar disorder in first-degree relatives of patients, and the 
concordance between monozygotic twins is around 40%, with an estimated 
heritability of around 80% (McGuffin, et al., 2003; Kieseppa, et al., 2004; 
Edvardsen, et al., 2008; Lichtenstein, et al., 2009; reviewed in Barnett and 
Smoller, 2009). Numerous genome-wide association studies (GWAS) have 
been performed to screen for genes involved in the heritability of bipolar 
disorder (Purcell, et al., 2009), and interestingly, several clock genes have been 
implicated in the pathophysiology. Variants in PER2, PER3, CLOCK, BMAL1 
and REV-ERB- (NR1D1) have been suggested to be associated with bipolar 
disorder, although replication studies have not always confirmed the findings 
(Mansour, et al., 2006; Nievergelt, et al., 2006; Shi, et al., 2008; Mansour, et 
al., 2009; Kishi, et al., 2009). 
 
1.5.3 Pharmacological treatment of bipolar disorder 
Drug therapy of bipolar disorder aims at attenuating mood fluctuations and 
preventing the occurrence of new episodes. The mood stabilizers lithium, 
valproic acid and carbamazepine are cornerstones in the pharmacological 
treatment (for guidelines, see Sachs, et al., 2000; American Psychiatric 
Association, 2000; Baldessarini, et al., 2010), and lithium has long been 
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considered the gold standard drug (Gershon, et al., 2009; Hirschowitz, et al., 
2010; for a review on the history of lithium treatment, see Schou, 2001). 
 
Manic phases of bipolar disorder typically present with elevated or irritable 
mood, distractibility, increased impulsivity and decreased need for sleep 
(American Psychiatric Association, 2000). Acute manic phases may be treated 
with a mood stabilizer, but also antipsychotic drugs such as olanzapine, 
risperidone, quetiapine or haloperidol are effective (reviewed in Fountoulakis 
and Vieta, 2008; Cipriani, et al., 2011). Often a combination of drugs from the 
two categories is used for optimal effect, with an underlying reasoning that the 
drugs have different and potentially complementary mechanisms of action 
(reviewed in Goodwin, et al., 2009). Main features of depressive episodes are 
depressed or irritable mood, apathy, psychomotor retardation and increased 
need for sleep (American Psychiatric Association, 2000). Depressive episodes 
may be treated with antidepressants in addition to a mood stabilizer (Sachs, et 
al., 2007; see consensus guidelines in Sachs, et al., 2000), although the risk of 
switching from depression to mania is present (reviewed in Fountoulakis, et al., 
2008). Being a chronic condition, bipolar disorder may require lifelong 
pharmacological treatment, which underlines the importance of optimizing the 
drug therapy. Lithium is widely used in long-term treatment, even though it has 
several limitations, including a narrow therapeutic window of serum 
concentration of 0.6-1.2 mM, where lower doses are ineffective, and patients 
may experience toxic effects if the serum concentration exceeds 1.5-2.0 mM 
(reviewed in Muller-Oerlinghausen, et al., 2002; Grandjean and Aubry, 2009). 
Another drawback is that not all patients respond to lithium treatment (for 
review, see Grof, et al., 2009). Still, since lithium may be highly effective in 
both acute manic and depressive phases, as well as in long-term prophylaxis, it 
is frequently the drug of choice (reviewed in Coryell, 2009; Gershon, et al., 
2009). 
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1.5.4 Lithium and the circadian clock 
It is intriguing that the alkali metal lithium, one of the most efficient drugs in 
the treatment of bipolar disorder, has been shown to modify circadian rhythms 
in humans and animals. Lithium prolonged the circadian rhythms in manic 
depressive patients (Kripke, et al., 1978) and in healthy controls (Johnsson, et 
al., 1983). Interestingly, the volunteers in the latter study were kept under 
constant conditions on the Norwegian island of Spitsbergen during the arctic 
midsummer, with little variation in light intensity and no additional external 
Zeitgebers. They displayed prolonged circadian oscillations of body 
temperature, locomotor activity and sleep-wake cycle with lithium 
administration (Johnsson, et al., 1983). Lithium has also been shown to prolong 
circadian rhythms in rats (McEachron, et al., 1982; Subramanian, et al., 1998) 
and yet other studies have demonstrated that lithium prolonged the locomotor 
activity period in fruit flies (Padiath, et al., 2004; Dokucu, et al., 2005). 
 
The main hypotheses for lithium action include its inhibition of inositol 
monophosphatase activity (the inositol depletion hypothesis) (Hallcher and 
Sherman, 1980; Berridge, et al., 1982; reviewed in Quiroz, et al., 2010) and its 
inhibition of the enzyme glycogen synthase kinase 3 (GSK-3) (Klein and 
Melton, 1996; Padiath, et al., 2004; reviewed in O'Brien and Klein, 2009). 
However, the exact underlying mechanisms of lithium action, and in particular 
how it modifies the circadian clock, have yet to be fully established. 
 
1.6 Circadian rhythms, energy metabolism and lipogenesis 
The circadian clock influences a large number of genes both directly and 
indirectly, and global gene expression studies have revealed that 2-10% of the 
mammalian transcriptome oscillates with circadian rhythmicity both in vivo in 
rodent SCN, liver and heart (Ueda, et al., 2002; Storch, et al., 2002; Panda, et 
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al., 2002) and also in vitro in cell cultures (Grundschober, et al., 2001; 
Duffield, et al., 2002). Interestingly, transcriptome studies further demonstrated 
that numerous genes involved in metabolic pathways oscillated (Akhtar, et al., 
2002; Miller, et al., 2007), indicating that the circadian clock participates in 
regulating energy metabolism. In fact, it has been shown that the two processes 
are closely connected, and new links between the circadian clock and lipid 
metabolism are gradually being discovered (reviewed in Staels, 2006; Green, et 
al., 2008). Circadian oscillations of metabolic factors are also observed at the 
functional level, as exemplified by the robust circadian rhythms of serum 
triglyceride levels (Figure 1.1) (Rajaratnam and Arendt, 2001), and the 
circulating amount of the appetite-regulating hormone leptin (Sinha, et al., 
1996; Licinio, et al., 1997). Interestingly, the diurnal rhythm of leptin has been 
shown to be SCN-dependent (Kalsbeek, et al., 2001), even though food intake 
and anticipation of food may influence rhythmicity in metabolic factors, 
including triglycerides and leptin (Ribeiro, et al., 1998; Ahren, 2000). 
 
Triglycerides, phospholipids and cholesterol are essential for energy storage, 
but they are also structural components of cell membranes and act as signaling 
molecules. Lipids are obtained in part from the diet, and in part synthesized 
endogenously de novo (reviewed in Lafontan, 2008). Excess carbohydrates in 
the diet are degraded to pyruvate and converted to fatty acids, which are 
subsequently synthesized to triglycerides. The liver is the main site for 
converting acetyl-CoA (an intermediate in the carbohydrate and lipid 
metabolism) via fatty acids to triglycerides (Figure 1.6), a process known as 
lipogenesis (for reviews, see Lafontan, 2008; Wakil and Abu-Elheiga, 2009; 
Voshol, et al., 2009). 
 
Major regulators of lipid biosynthesis gene transcription are the sterol 
regulatory element-binding proteins (SREBPs) (Figure 1.6) (reviewed in 
Bengoechea-Alonso and Ericsson, 2007; Raghow, et al., 2008). The SREBP 
family consists of three isoforms, SREBP-1a, SREBP-1c and SREBP-2, where 
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the two splice variants SREBP-1a and SREBP-1c are encoded by the same 
gene. To a large extent, the different isoforms of SREBP modulate different 
aspects of lipid synthesis. SREBP-1c preferentially regulates synthesis of 
triglycerides and phospholipids, controlling transcription of genes encoding 
key enzymes in lipogenesis, including acetyl-coenzyme A carboxylase  
(Acaca), fatty acid synthase (Fasn), fatty acid desaturase 2 (Fads2), stearoyl-
Coenzyme A desaturase 1 (Scd1) and stearoyl-Coenzyme A desaturase 2 
(Scd2) (Nakamura, et al., 2004; reviewed in Shimano, 2009). The isoform 
SREBP-2 primarily regulates genes involved in cholesterol synthesis, such as 
3-hydroxy-3-methylglutaryl-CoA reductase (Hmgcr) and mevalonate kinase 
(Mvk), whereas the isoform SREBP-1a modifies the transcription of genes in 
both pathways, but primarily promotes fatty acid synthesis (reviewed in 
Bengoechea-Alonso and Ericsson, 2007; Raghow, et al., 2008). 
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Figure 1.6. SREBP pathways and synthesis of triglycerides, phospholipids and 
cholesterol. The isoform SREBP-1c preferentially regulates transcription of genes involved 
in the synthesis of triglycerides and phospholipids, whereas SREBP-2 preferentially activates 
genes involved in cholesterol synthesis. SREBP-1a modifies the transcription of genes in both 
pathways. Diagram by Osland TM (modified from Horton, et al., 2002). 
 
1.7 Psychotropic drugs and SREBP activation 
Bipolar patients are vulnerable to weight gain and metabolic disturbances, and 
pharmacological treatment involving drugs associated with weight gain is one 
of the leading explanations for the associated obesity (McElroy, et al., 2002; 
Correll, 2007; for review, see Fagiolini, et al., 2008). Many antipsychotic 
drugs, such as clozapine and olanzapine, as well as some antidepressants, 
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including imipramine, have been shown to stimulate transcription of 
cholesterol and triglyceride genes in vitro in cell cultures (Ferno, et al., 2006; 
Raeder, et al., 2006b; Yang, et al., 2007) and in vivo in rats (Minet-Ringuet, et 
al., 2007; Ferno, et al., 2009). These genes are controlled by SREBP 
transcription factors (reviewed in Shimano, 2009; Sato, 2010), and the SREBP 
system has been proposed to be involved in the weight gain often associated 
with antipsychotics and antidepressants (Le Hellard, et al., 2009). The degree 
of SREBP activation varies between the drugs, and among the potent SREBP 
activators we find the antipsychotics clozapine, olanzapine and haloperidol, 
and the antidepressants imipramine and amitriptyline (Ferno, et al., 2006), 
whereas among the weaker SREBP activators we find the antipsychotic 
ziprasidone. The mood stabilizers lithium, valproic acid and carbamazepine 
appear not to activate SREBP (Ferno, et al., 2006; Raeder, et al., 2006a; 
Raeder, et al., 2006b). 
 
Schizophrenia is a major mental illness, characterized by positive symptoms, 
such as delusions, hallucinations (auditory or visual) and disorganization of 
speech, as well as negative symptoms, which include flattening of affect and 
poverty of speech or thought (reviewed in Freedman, 2003; Tamminga and 
Holcomb, 2005; American Psychiatric Association, 2000). Patients may also 
present with cognitive dysfunction, including impairment of memory, 
executive function and motor skills (Bilder, et al., 2000). Antipsychotics are 
considered the cornerstone of schizophrenia treatment, and include first-
generation antipsychotics, which mainly act by reducing positive symptoms, 
such as haloperidol, and second-generation antipsychotics, including clozapine 
and olanzapine, that may improve both positive and negative symptoms 
(reviewed in Freedman, 2003). In the clinical setting, clozapine has been 
associated with substantial weight gain and dyslipidemia (Cohen, et al., 1990; 
Leadbetter, et al., 1992) and severely low white blood cell count 
(agranulocytosis) (Alvir, et al., 1993). In vitro, clozapine causes pronounced 
SREBP activation with subsequent lipogenesis (Ferno, et al., 2005; Raeder, et 
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al., 2006b). Despite the possible complications of the drug, it remains a potent 
antipsychotic that may be effective in treatment-resistant schizophrenia (Kane, 
et al., 1988; reviewed in McIlwain, et al., 2011). Noteworthy, clozapine may 
also be used to improve symptoms of bipolar disorder (for review, see Ertugrul 
and Meltzer, 2003). 
 
Imipramine was the first tricyclic antidepressant to be developed in the 1950s 
(Azima and Vispo, 1958). It is a potent drug, but has to a large extent been 
replaced by newer classes of antidepressants, in particular selective serotonin 
reuptake inhibitors (SSRIs) that are better tolerated and have fewer side effects 
(reviewed in Wood, et al., 2002). Nevertheless, it remains an important tool for 
the investigation of antidepressant drugs. Imipramine has been associated with 
marked weight gain in patients (Berken, et al., 1984; Fernstrom, et al., 1986), 
and in cell culture it causes pronounced activation of the SREBP system, 
followed by lipogenesis (Raeder, et al., 2006a; Raeder, et al., 2006b). A meta-
analysis reported that although imipramine prevents depressive episodes in 
bipolar patients, it is little used in the clinic due to its side effects (Beynon, et 
al., 2009).  
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2  Aims of the study 
The overall aim of this study was to explore the role of clock genes in 
psychotropic drug effects and on selected biological functions (lipid 
metabolism and sleep). Specifically, we had the following objectives: 
1. Use a cell culture model of the circadian clock to explore the 
rhythmicity of clock gene expression, and investigate the effects of the 
mood stabilizer lithium on the transcription of clock genes (paper I) 
2. Identify and compare the effects of different psychotropic drugs, 
including the antipsychotic clozapine and the antidepressant 
imipramine, on the transcription of genes involved in the control of 
circadian rhythms and lipid metabolism (paper II) 
3. Examine and genotype a population of Norwegian students to 
investigate the influence of a VNTR in the clock gene PER3 on diurnal 
preference (paper III) 
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4  Summary of results 
4.1 Paper I 
We used an in vitro model of the circadian clock to perform a comprehensive 
study of the gene expression profiles of the clock genes Per1, Per2, Per3, 
Cry1, Cry2, Bmal1, Clock, Rev-Erb-, Ror-, Gsk-3, Csnk1, E4bp4 and Dbp 
for three consecutive days. Serum-shocked cultures of mouse fibroblasts (NIH-
3T3 cells) displayed rhythmic gene expression patterns of clock genes with a 
variety of phases and amplitudes, with peaks of expression levels distributed 
throughout the cycle. We examined the effects of lithium on clock gene 
expression, and found that lithium increased the peak amplitude of expression 
of Per2 and Cry1, whereas the peak amplitudes of expression of Per3, Cry2, 
Bmal1, E4bp4, Rev-Erb- and Ror- were reduced. Moreover, the period of 
Per2 was apparently prolonged by lithium. In light of the proposed role of 
circadian rhythm disturbances in bipolar disorder, these differential effects on 
clock gene expression could reflect a mechanism for the effects of lithium on 
circadian rhythms that may be relevant for its therapeutic effects in the 
treatment of bipolar disorder. 
 
4.2 Paper II 
The effects of lithium on the circadian clock have been suggested to be 
therapeutically relevant for the treatment of bipolar disorder. Additional mood 
stabilizing agents, antidepressants and antipsychotics have also been implicated 
in the pharmacological treatment; hence we explored and compared their 
effects on clock gene transcription. Since several antipsychotics and 
antidepressants are known to induce lipogenic gene expression, and given the 
accumulating evidence for a link between the circadian clock and lipid 
metabolism, we also investigated drug effects on the expression of lipid 
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biosynthesis genes. Lithium, imipramine and clozapine were investigated for 
effects on serum-shocked NIH-3T3 cells in a time course experiment. Clock 
genes displayed robust circadian rhythms, in contrast to lipid biosynthesis 
genes, suggesting that circadian oscillations in clock genes were not conveyed 
to the lipid metabolism genes in this model system. The effects of clozapine 
and imipramine differed partly from the effects of lithium, including reduced 
expression of Per2 by imipramine and clozapine, and increased Rev-Erb- 
expression levels by clozapine, indicating that the drugs act on the circadian 
clock via different mechanisms. Lithium had no effect on the expression of 
lipid metabolism genes, in contrast to the marked up-regulation caused by 
imipramine and clozapine. A panel of additional psychotropic drugs was 
examined at one time point in a separate experiment. The investigated 
antipsychotics and antidepressants had similar effects to clozapine and 
imipramine, suggesting drug class effects. The observed drug effects could 
reflect some shared regulatory mechanisms that contribute to their psychotropic 
action. 
 
4.3 Paper III 
Polymorphisms in clock genes could be associated with differences in 
circadian rhythms, and interest in their impact on circadian parameters, 
including diurnal preference, is growing due to potential relevance for physical 
and mental health. For instance, the circadian clock heavily influences timing 
of sleep, and associations between sleep and various complications have been 
reported, including obesity and psychiatric disorders. Several studies have 
investigated the role of a VNTR in the clock gene PER3, where the short allele 
of the VNTR has been associated with diurnal preference and with DSPD, but 
conflicting findings have also been reported. We performed a replication study 
to explore the role of this PER3 polymorphism on diurnal preference in a 
sample of 432 Norwegian university students. The widely used Horne-Östberg 
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Morningness Eveningness Questionnaire (MEQ) and the Preferences Scale 
(PS) were used to assess chronotype. We found no association between the 
PER3 VNTR and diurnal preference, indicating that the proposed role of PER3 
needs further clarification. 
  
  
38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is the theory which decides what we can observe. 
 
 
 
 
Albert Einstein 
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5  Discussion 
5.1 Selected methodological aspects 
5.1.1 Serum-shocking of cultured cells 
In this study, we explored circadian rhythms by examining the transcription of 
selected clock genes in cell culture. Circadian rhythms in cultured cells may be 
entrained by several factors, including exposure to a high dose (50%) of horse 
serum for two hours (serum shock) (Balsalobre, et al., 1998; Allen, et al., 
2001), the glucocorticoid hormone dexamethasone (Balsalobre, et al., 2000a), 
tissue plasminogen activator (Akashi and Nishida, 2000) and forskolin (Yagita 
and Okamura, 2000), indicating that various pathways are involved in the 
synchronization of circadian rhythms in peripheral clocks (Balsalobre, et al., 
2000b). We chose to use serum-shocking for entrainment, as serum contains a 
large number of signaling factors, and might be thought to stimulate several of 
the involved pathways for circadian entrainment. 
 
 It has been shown that a serum shock may synchronize the circadian rhythms 
in several cell lines, including Reuber's rat hepatoma cells (H-35) and mouse 
fibroblasts (NIH-3T3) (Balsalobre, et al., 1998; Akashi and Nishida, 2000). 
Nevertheless, we screened numerous cell types in search of an additional cell 
line (derived from a target organ of lithium treatment) which might be more 
relevant for bipolar disorder and the known side effects of lithium, including 
human glioma cells (GaMg), human hepatoma cells (HepG2), human kidney 
cells (HK-2), human thyroid cells (Nthy-ori 3-1), rat glioma cells (C6), H-35 
and NIH-3T3 cells. However, only the latter two cell lines displayed robust 
oscillations in clock gene expression after serum-shocking (Osland, et al., 
unpublished data), in agreement with previous studies (Balsalobre, et al., 1998; 
Akashi and Nishida, 2000). In contrast to the H-35 cells, NIH-3T3 cells were 
highly contact-inhibited, which is essential in serum shock experiments to 
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avoid potential biases caused by cell division; hence we chose the latter cell 
line for our studies. 
 
Circadian rhythms of NIH-3T3 cells were synchronized by serum-shocking 
confluent cultures. As predicted from the literature, robust oscillations were 
generated of rhythmic clock genes (e.g. Per2, Cry1 and Rev-Erb-) with a 
variety of different phases (Balsalobre, et al., 1998; Oishi, et al., 1998a; Mitsui, 
et al., 2001; reviewed in Hastings and Herzog, 2004), whereas other clock 
genes were expressed at constant levels (e.g. Clock, Csnk1 and Ror-) 
(Shearman, et al., 1999; Shearman, et al., 2000; Preitner, et al., 2002; 
Maywood, et al., 2003; Guillaumond, et al., 2005; for review, see Ko and 
Takahashi, 2006). In line with previous studies, we found a gradual damping 
over time of the oscillations (Yamazaki, et al., 2000; reviewed in Hirota and 
Fukada, 2004), which was attributed to lack of feedback, causing the cells to 
gradually fall out of phase with each other. This may, at least in part, be due to 
the individual cells containing autonomous clocks, each with their own period, 
causing the cells to require continuous entrainment in order to remain 
synchronized to one another. The damping effect limited the observation time, 
but nevertheless we observed robust oscillations for three consecutive days (i.e. 
three full circadian cycles). We observed only minor biological and technical 
variation, such as effects of the number of times the cells had been subcultured 
(passage number), and on the whole we found relatively little variation 
between the experiments. In summary, cell culturing provided a simplified and 
robust model to study clock gene expression, and the model could provide 
results that are relevant for circadian clocks in vivo. 
 
5.1.2 Selection of psychotropic drugs and dosage 
NIH-3T3 cell cultures were exposed to psychotropic drugs in order to 
investigate potential effects on the expression of genes involved in the 
circadian clock or lipid biosynthesis. We aimed at using drug doses that were 
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sufficiently high to produce effects in vitro on the target genes in question, but 
not so high as to cause cell toxicity. Hence, the investigated drug doses often 
markedly exceeded relevant serum concentrations in patients, but it is common 
to study high drug doses in vitro (Iitaka, et al., 2005; Kaladchibachi, et al., 
2007; Wu, et al., 2007). Lithium is known to affect the circadian clock by 
mechanisms that remain largely unknown, and we therefore studied its effects 
on clock gene expression. As mentioned in the Introduction, lithium has a 
narrow therapeutic plasma concentration range of 0.6-1.2 mM in humans 
(reviewed in Muller-Oerlinghausen, et al., 2002; for review on lithium toxicity, 
see McKnight, et al., 2012), although much higher drug concentrations (20 
mM) are tolerated in vitro in cell culture (Iitaka, et al., 2005; Yin, et al., 2006; 
Wu, et al., 2007). Since we found dose-dependent effects of lithium on clock 
genes, with no significant toxicity up to 20 mM lithium chloride as determined 
by flow cytometry, we used this latter concentration to obtain pronounced 
effects of the drug (paper I and paper II). 
 
In addition to mood stabilizers, antipsychotics and antidepressants are effective 
in the treatment of bipolar episodes (Goodwin, et al., 2009; Cipriani, et al., 
2011), and we therefore explored their effects on the transcription of clock 
genes. Antipsychotic and antidepressant drugs have often been associated with 
weight gain, dyslipidemia and type 2 diabetes (reviewed in Allison, et al., 
2009; Raedler, 2010). Since new links between the circadian clock and lipid 
metabolism are continuously emerging (reviewed in Asher and Schibler, 2011), 
we also studied drug effects on the transcription of lipid biosynthesis genes, 
and whether drug-induced effects on clock genes and lipogenic genes 
corresponded (paper II). We investigated effects of imipramine, a prototypical 
tricyclic antidepressant, and the second-generation antipsychotic clozapine, 
both potent SREBP activators (Ferno, et al., 2005; Raeder, et al., 2006a) that 
have been associated with substantial weight gain in patients (Berken, et al., 
1984; Fernstrom, et al., 1986; Cohen, et al., 1990; Leadbetter, et al., 1992; 
Lamberti, et al., 1992; for review, see Allison, et al., 1999; Asenjo Lobos, et 
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al., 2010). We examined the effects of 15 M imipramine, which is within the 
range of concentrations where activation of the SREBP system is expected, 
without toxic drug effects in the cells (Sukma, et al., 2003; Raeder, et al., 
2006a; Vik-Mo, et al., 2009). Correspondingly, based on previous studies 
(Ferno, et al., 2006; reviewed in Ferno, et al., 2011), we exposed the cell 
cultures to 30 M clozapine. The selected concentrations are considerably 
higher than the recommended target plasma concentrations in patients (0.6-1.1 
M imipramine and 1.1-1.8 M clozapine) (Baumann, et al., 2004), but the use 
of high doses may in part be justified by the lipophilic properties of the drugs, 
which cause them to have large volumes of distribution in the body, with a 
tendency towards drug-accumulation in the brain and adipose tissues. In line 
with this, the concentration of clozapine has been found to be over 15 times 
higher in the rat brain than in serum (Weigmann, et al., 1999). 
 
To explore whether the transcriptional changes observed for lithium, 
imipramine and clozapine on circadian gene expression could be generalized to 
hold for their respective psychotropic drug classes, we investigated a panel of 
representative mood stabilizers, antidepressants and antipsychotics for effects 
on clock genes and lipid metabolism genes. The mood stabilizers valproic acid 
and carbamazepine, the antidepressants amitriptyline (tricyclic antidepressant) 
and fluoxetine (SSRI), the first-generation antipsychotic haloperidol, and the 
second-generation antipsychotic drugs clozapine, olanzapine, quetiapine, 
aripiprazole and ziprasidone were included in the panel. Hence, both potent 
activators of the SREBP system, such as clozapine, olanzapine and haloperidol, 
along with drugs with low lipogenic potential, including aripiprazole and 
ziprasidone, were represented in the panel. We investigated drug effects at one 
time point, 24 hours after a serum shock, based on the time course experiments 
with lithium, imipramine and clozapine, since several clock genes are expected 
to peak at that time point, and drug effects should also be around their maxima 
(Ferno, et al., 2005; Raeder, et al., 2006a). We used a fixed concentration of 25 
M of each drug, which based on earlier studies was expected to be well 
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tolerated in cell culture, and be sufficiently high to produce effects (Koch, et 
al., 2003; Ferno, et al., 2005; Levkovitz, et al., 2005; Raeder, et al., 2006a; 
Kato, et al., 2008; Vik-Mo, et al., 2009; Lauressergues, et al., 2010). Of note, 
these drugs have very different target plasma concentrations in patients, but we 
used a single drug concentration to make a simple comparison between the 
agents. Drug effects on gene expression levels were compared to the effects of 
20 mM lithium chloride, which had previously been studied comprehensively 
(paper I). We used 0.05% dimethyl sulfoxide (DMSO) as a solvent due to the 
low solubility of certain psychotropics, and although it might have stimulated 
lipogenesis due to its lipophilic compound and influenced our results, we found 
no significant difference between controls with or without DMSO (data not 
shown). 
 
5.1.3 Quantitative real-time PCR 
Quantitative real-time polymerase chain reaction (qRT-PCR) is a sensitive 
technique to quantify mRNA levels of specific genes. In complementary DNA 
(cDNA) synthesis, mRNA is reverse transcribed to cDNA, before targeted 
DNA strands are repeatedly amplified and quantified in qRT-PCR. The 
procedure is widely used, as it only requires small amounts of test material and 
yields reproducible results. TaqMan chemistry or the fluorescent dye SYBR 
Green may be used in the qRT-PCR to measure fluorescence intensity (in real-
time) after each PCR cycle. SYBR Green detects all double-stranded DNA, 
meaning it can be used with any given primer pair, but it may create false 
positive signals due to nonspecific amplification products. On the other hand, 
TaqMan probes only detect specific amplicons, but a different probe is required 
for each primer pair. Since we obtained consistent results for our primer pairs 
with SYBR Green, and since TaqMan chemistry is far more expensive, we 
preferentially used SYBR Green, although TaqMan probes were used for some 
of the assays. 
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The mRNA levels of the genes of interest are usually normalized to the amount 
of one or more endogenous reference genes (so-called housekeeping genes) in 
the same sample. However, in our experiments we observed that one of the 
reference genes was affected by the serum shock (-actin (Actb)), and others 
were sensitive to drug exposure (Gapdh and -2 microglobulin (B2M)). Drug 
response was observed when cell cultures were exposed to clozapine or 
imipramine, hence to remedy for this, we used the mean of several endogenous 
controls (ribosomal protein, large, P0 (Rplp0), Actb and B2M) for 
normalization in the experiments involving antipsychotics and antidepressants 
(paper II). It is difficult to find appropriate reference genes that remain 
invariant to all aspects of experimental conditions, but in support of our 
selection, none of the used reference genes displayed circadian oscillations, and 
moreover, the results were highly similar with and without normalization to the 
reference genes. 
 
The qRT-PCR data was analyzed using both the standard curve method and the 
comparative  Ct method. A dilution series of cDNA lies at the base for 
quantification of the samples with the standard curve method. Alternatively, 
corresponding dilutions at the RNA level may be used to create a standard 
curve, but high RNA concentrations might cause inhibition during cDNA 
synthesis, which would result in a flattening of the standard curve, and could 
bias the results. For the comparative  Ct method, no standard curve is 
needed, but it is required that the amplification efficiencies of the primers for 
the gene of interest and the reference gene are similar. Both methods calculate 
the fold change in expression of a gene of interest relative to a reference gene, 
in a treated sample compared to one or several calibrator samples (generally 
controls or untreated samples are used). Moreover, both methods assume that 
the amplification efficiency remains constant for each PCR cycle and in all 
samples. However, this may not always be the case and could influence the 
outcome. We observed minor differences in the results using the two methods 
of analysis, with the standard curve method estimating slightly greater 
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differences between controls and drug-exposed samples, compared to the  Ct 
method. Nevertheless, the two methods essentially coincided, and we switched 
from the standard curve method (paper I) to the  Ct method for the 
experiments with antipsychotics and antidepressants (paper II), due to the large 
sample size in paper I, since the  Ct method minimizes the number of 
reactions required, as a standard curve is not necessary for each run. However, 
results at the gene expression level cannot be extrapolated directly to functional 
effects, and confirmation of the results at the protein level would have been 
valuable for the interpretation. 
 
5.1.4 Mathematical and statistical analysis 
We applied several methods to describe the circadian oscillations and analyze 
drug effects. In the experimental setup in paper I, with serum-shocked cells 
exposed to lithium or vehicle, a squared sine function was used to approximate 
the oscillations and detect changes in gene expression caused by lithium. 
Parameters such as period, amplitude and phase were calculated, and we found 
significant effects of lithium on several genes, mainly on the amplitude of 
expression. In addition to approximating the data with the mathematical model, 
we performed a two-way analysis of variance (ANOVA) for each gene, with 
main effects for time and treatment (drug versus control), along with an 
interaction term between the two. The mathematical model was more 
restrictive than ANOVA and the two techniques did not always give fully 
concordant results. Discrepancies were attributed to limitations of the model in 
describing the observed oscillations. Due to the large variation in the ability of 
the functions in the mathematical model to approximate the oscillations, we 
based our conclusions on two-way ANOVA results for the data from the time 
course experiments comparing effects of lithium, imipramine and clozapine 
(paper II). In cases where the interaction term was significant in addition to the 
main effects, it was less straightforward to interpret drug effects, and the 
analysis was followed up with Dunnett's post-hoc test. Treatment groups were 
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subsequently compared using one-way ANOVA at each single time point, 
followed by Dunnett's post-hoc test of pairwise comparison of the treated 
samples with the controls. Finally, to examine individual time points for 
significant effects in the drug panel experiment, we performed t-tests (paper II). 
 
5.2 Circadian rhythms in clock genes and lipid metabolism 
genes 
5.2.1 Circadian oscillations in clock gene expression 
Exposing confluent cell cultures of mouse fibroblasts (NIH-3T3 cells) to a 
serum shock, represents a useful technique for studying peripheral circadian 
clocks in vitro. The serum shock generated robust circadian oscillations of 
approximately 24 hours in the transcription levels of the majority of the clock 
genes we investigated. The rhythmic clock genes displayed a variety of phases 
and amplitudes, and were in agreement with previous reports (Balsalobre, et 
al., 1998; Mitsui, et al., 2001; for review, see Hastings and Herzog, 2004). For 
instance, Per2 expression peaked around 24 and 48 hours, and was in antiphase 
with Bmal1 (Oishi, et al., 1998a; reviewed in Hirota and Fukada, 2004), that 
peaked around 36 and 64 hours (Figure 1.3A). We did not detect oscillations in 
the expression patterns of some of the clock genes, such as Clock, Csnk1 and 
Ror-, in line with previous studies reporting that they are constitutively 
expressed (Shearman, et al., 1999; Shearman, et al., 2000; Maywood, et al., 
2003; Guillaumond, et al., 2005; reviewed in Ko and Takahashi, 2006). Taken 
together, the observed expression patterns support the validity of this model 
system of a peripheral circadian clock. 
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5.2.2 Links between the circadian clock and lipid metabolism 
Obesity represents a major health challenge worldwide, and has become the 
most common health disorder among young people in Europe (Obesity: 
preventing and managing the global epidemic, 2000; Doak, et al., 2012; 
reviewed in Oster, 2010). In light of the numerous proposed links between the 
circadian clock and lipid metabolism (reviewed in Froy, 2011; Huang, et al., 
2011; Delezie and Challet, 2011), it is highly interesting that short sleep is 
associated with obesity, diabetes and the metabolic syndrome (Grandner, et al., 
2011; for review, see Knutson, et al., 2007; Oster, 2010). Furthermore, shift 
workers have an increased incidence of obesity and diabetes (Karlsson, et al., 
2001; reviewed in Huang, et al., 2011). The SCN is entrained by light, but not 
by food, hence shifts in feeding (as seen in shift workers) may rapidly uncouple 
peripheral clocks (such as the liver clock) from the SCN clock (Damiola, et al., 
2000; Stokkan, et al., 2001), leading to misalignments that may pave the way 
for metabolic disturbances (reviewed in Delezie and Challet, 2011; Albrecht, 
2012). Further emphasizing the impact of food on regulating circadian 
rhythms, a recent global gene expression study demonstrated that in the 
absence of food, the number of rhythmic transcripts dropped markedly in 
mouse liver, while feeding restored cyclic transcription of several hundreds of 
genes (Vollmers, et al., 2009). In addition to being modified by food intake, the 
peripheral clock in the liver is synchronized centrally by the SCN. In fact, the 
circadian clock and lipid metabolism reciprocally influence each other (Figure 
5.2.2) (Vollmers, et al., 2009; reviewed in Staels, 2006; Green, et al., 2008). 
 
It has been shown that mutations of the clock genes Clock and Bmal1 lead to 
adverse metabolic effects in mice, including obesity, diabetes and dyslipidemia 
(Turek, et al., 2005; Shimba, et al., 2011). Also Per2 (Yang, et al., 2009a) and 
Rev-Erb- (Raspe, et al., 2002) have been implicated in the development of 
metabolic disturbances, emphasizing the crucial role of the circadian clock in 
lipid homeostasis.  Further suggesting a reciprocal link between the circadian 
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clock and lipid metabolism, obese rats with a mutation in the leptin receptor 
(Zucker rats) have phase-advances of activity, feeding and body temperature 
rhythms, and the amplitudes of these circadian oscillations are attenuated 
(Fukagawa, et al., 1992; Murakami, et al., 1995; Mistlberger, et al., 1998). 
 
The mechanisms that couple these two processes are poorly understood, but 
numerous genes have been implicated in the interaction at the molecular level 
(for review, see Green, et al., 2008; Bass and Takahashi, 2010; Asher and 
Schibler, 2011). Various clock genes contribute to modifying lipid metabolism, 
such as Per2 regulating peroxisome proliferator activated receptor  (Ppar-) 
function (Grimaldi, et al., 2010; Schmutz, et al., 2010), Rev-Erb- modulating 
SREBP target genes (Anzulovich, et al., 2006; Le Martelot, et al., 2009), and 
Bmal1 has been implied in glucose and lipid metabolism (Rudic, et al., 2004; 
Shimba, et al., 2005). Also downstream transcription factors of the circadian 
clock, such as Dbp, Hlf and Tef are involved in lipid metabolism (reviewed in 
Staels, 2006). Conversely, several metabolic regulators influence the circadian 
clock, including AMP-activated protein kinase (AMPK) that modulates 
circadian rhythms by phosphorylating the clock component CRY1 (Lamia, et 
al., 2009; reviewed in Fan, et al., 2012), Ppar- regulating Bmal1 transcription 
(Wang, et al., 2008; reviewed in Kawai and Rosen, 2010) and peroxisome 
proliferator activated receptor  coactivator 1 (Pgc-1) promoting 
transcription of Bmal1 and  Rev-Erb- (Liu, et al., 2007). 
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Figure 5.2.2. Interaction between the circadian clock and lipid metabolism. Light 
synchronizes the pacemaker in the SCN to the environment, whereas circulating hormones 
and food intake contribute to modifying peripheral oscillators. Output signals from the clock 
may influence metabolism, and for instance the transcription factors Rev-Erb-, Dbp, Hlf and 
Tef are among the targets of the circadian clock that in turn regulate metabolism. Reproduced 
from Staels with permission of the author (Staels, 2006). 
 
To explore the links between the circadian clock and lipid metabolism, we 
investigated the transcription of several lipid biosynthesis genes and compared 
them to expression profiles of clock genes. In vivo, it has been shown that the 
expression levels of numerous lipid metabolism genes oscillate, such as 
peroxisome proliferator activated receptor  (Ppar-) in rats (Lemberger, et 
al., 1996), or Fasn, Hmgcr and Ppar- in mice (Patel, et al., 2001; Oishi, et al., 
2005). However, in our model system, a serum shock with subsequent clock 
gene oscillations was not sufficient to entrain circadian rhythms in the lipid 
metabolism genes Fads2, Hmgr, Scd1 or Scd2. Our results are in agreement 
with previous studies in NIH-3T3 cells under similar experimental conditions, 
where a serum shock was not sufficient to induce circadian metabolic activity 
(Allen, et al., 2001; Hughes, et al., 2009). The observed lack of rhythmicity in 
vitro could at least partly be due to the absence of additional factors 
(Zeitgebers) present in vivo, such as hormones or nutritional status, and it 
  
50 
would appear that the mechanisms required for oscillation of clock genes and 
lipid metabolism genes are independent of each other in this model system. In 
addition, microarray studies have demonstrated that rhythmicity is highly 
tissue-specific, with large variation in the set of genes that oscillate in the 
different tissues, and minimal overlap from study to study (Panda, et al., 2002; 
Storch, et al., 2002; Zvonic, et al., 2006; Menger, et al., 2007; Miller, et al., 
2007), which was proposed to be caused by applying different algorithms to 
detect oscillation (see Doherty and Kay, 2010 for review). This tissue-specific 
rhythmicity could also in part explain the lack of rhythmicity in our 
experimental set-up. 
 
5.3 Psychotropic drug effects on clock genes and lipid 
metabolism genes 
5.3.1 Psychotropic drugs differentially alter the amplitudes of clock 
gene expression 
We investigated the effects of lithium on circadian rhythms in an established in 
vitro model of the circadian clock. Lithium differentially changed the 
amplitude of several clock genes, including an increase in the oscillation 
amplitude of Per2 and Cry1 expression, whereas the amplitudes of Per3, Cry2, 
Bmal1, Rev-Erb-, Ror- and E4bp4 were reduced (paper I). In previous 
studies on lithium, the focus has mainly been on its lengthening effect on 
circadian rhythms in humans (Kripke, et al., 1978; Johnsson, et al., 1983) and 
animals (McEachron, et al., 1982; Subramanian, et al., 1998; Klemfuss, et al., 
1992; Padiath, et al., 2004), although lithium has also been reported to reduce 
the oscillation amplitudes of neurotransmitter receptors (Kafka, et al., 1982). 
However, only the period of Per2 was apparently prolonged by lithium in our 
experimental setup (paper I). In line with our results, a recent study 
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demonstrated that lithium increased the oscillation amplitude of both gene 
expression levels and protein amount in mice, in addition to a prolonged period 
of Per2 expression in vivo and in vitro (Li, et al., 2012). Moreover, another 
study found no alteration in the period of gene expression, and only altered 
amplitudes of the oscillations were reported, including reduced amplitudes of 
BMAL1, DBP and REV-ERB- expression in fibroblasts from bipolar patients 
compared to controls (Yang, et al., 2009b). Along with our findings, these 
studies provided new leads for the association between bipolar disorder and 
circadian rhythms, and suggest a possible role for the oscillation amplitudes of 
clock genes in the pathophysiology of bipolar disorder. This is further 
supported by studies demonstrating that subjects suffering from depression (a 
disorder with many similarities to bipolar disorder) have blunted amplitudes of 
circadian parameters, including body temperature and plasma melatonin levels, 
and moreover, the deficient amplitudes are restored in remission (Souetre, et 
al., 1989; Szuba, et al., 1997). 
 
Additional mood stabilizers, antidepressants and antipsychotics have also been 
implicated in the treatment of bipolar disorder, and we investigated whether 
such psychotropic drugs also affect the transcription of key circadian clock 
genes. Interestingly, we found that clozapine and imipramine also affected the 
transcription levels of various clock genes, including a down-regulation of 
Per2 by both drugs, and an up-regulation of Rev-Erb- expression by clozapine 
(paper II). Moreover, several other psychotropics and antidepressants also had 
significant effects on clock gene expression, indicating that alteration of clock 
gene transcription is not specific for lithium, and may be a common feature of 
several psychotropic drugs. In fact, it has been reported by others that valproic 
acid increased Per2 and Cry1 expression in mouse and human fibroblasts 
(Johansson, et al., 2011), fluoxetine differentially augmented or reduced the 
expression levels of Clock, Bmal1, Per1, Per2 and Cry2 in the mouse brain 
(Uz, et al., 2005) and haloperidol increased Per1 expression in mouse SCN 
(Viyoch, et al., 2005), suggesting that modification of circadian rhythms could 
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represent shared regulatory mechanisms that are relevant for their therapeutic 
effects. 
 
5.3.2 Transcriptional effects of psychotropic drugs on clock genes 
and lipid metabolism genes 
Although imipramine and clozapine had effects on clock genes, the 
transcriptional patterns differed from lithium (paper II). This suggests drug-
specific regulation of clock genes, which is emphasized by other differences 
between the drugs, such as the activation of lipogenic gene transcription by 
clozapine and imipramine, not observed by lithium. Examination of additional 
mood stabilizers (the antiepileptics valproic acid and carbamazepine), 
antidepressants (amitriptyline and fluoxetine) and antipsychotics (olanzapine, 
haloperidol, quetiapine, aripiprazole and ziprasidone) at one time point (24 
hours) following a serum shock, revealed similar drug effects to what had been 
observed for lithium, imipramine and clozapine, respectively, suggesting drug 
class effects (paper II). In contrast to the antipsychotics and antidepressants, the 
mood stabilizers only had minor effects on lipid metabolism genes, and it 
would appear that mood-stabilizing agents regulate clock genes independently 
of lipid metabolism genes (at least in vitro). This indicates that no evident 
regulatory link between the circadian clock and lipid metabolism is present in 
this model system, although it cannot be excluded. We found no significant 
effects by valproic acid or carbamazepine on any gene, and previous studies on 
the action of these mood stabilizers on circadian rhythms have been few and 
contradictory (Klemfuss and Kripke, 1995; Dokucu, et al., 2005). It is possible 
that higher drug concentrations would have had effect on the circadian clock, 
as has recently been reported for 1 mM valproic acid (Johansson, et al., 2011). 
However, in support of our negative finding for valproic acid on clock genes, 
no effect on lipid metabolism genes was found at this concentration either 
(Raeder, et al., 2006a). 
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5.3.3 Post-transcriptional modifications of clock proteins 
Our main focus on drug effects on the circadian clock has been at the gene 
expression level, and even though we found several interesting leads to pursue, 
future experiments should include protein and functional studies, since it has 
been suggested that post-transcriptional mechanisms represent important 
circadian control points (Lee, et al., 2001). As an example, the hepatic 
proteome of mice was examined for rhythmicity. It was demonstrated that 20% 
of the proteome oscillated, and moreover, for around half of the rhythmic 
proteins, the levels of the corresponding mRNAs did not display circadian 
oscillations (Reddy, et al., 2006). 
 
The kinase GSK-3 has been associated with the circadian clock (Padiath, et 
al., 2004; Kaladchibachi, et al., 2007), and the phosphorylation level of GSK-
3 is cyclic, as opposed to the protein amount (Iitaka, et al., 2005), suggesting 
that important regulation of the circadian clock occurs by post-translational 
modification. GSK-3 has is a known target of lithium (Klein and Melton, 
1996; Stambolic, et al., 1996), and it was recently demonstrated that 
overexpression of Gsk-3 rescued behavioral effects of lithium-treated mice 
(O'Brien, et al., 2011). We found that lithium treatment did not alter the 
transcription levels of Gsk-3 (paper I), whereas a significant difference at the 
phosphorylation level was observed (Osland, et al., unpublished data), with 
lithium augmenting the phosphorylation status of GSK-3, in line with a 
previous report (Iitaka, et al., 2005). These authors found that overexpression 
of GSK-3 caused a phase advance of clock gene expression, whereas 
inhibition gave a phase delay, and proposed that GSK-3 might contribute to 
modulating circadian rhythms by regulating the nuclear entry of PER2, since 
GSK-3 phosphorylates and activates PER2 (Iitaka, et al., 2005). Lithium 
inhibits GSK-3 by phosphorylation, and could thus delay nuclear 
translocation of PER2, and consequently prolong the period. In support of this 
role for PER2 in determining the length of circadian rhythms, it has been 
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shown that phosphorylation of PER2 at different phosphorylation sites may be 
used to prolong or shorten the period length in oscillating cell cultures 
(Vanselow, et al., 2006). The observed effects of lithium on the 
phosphorylation status of GSK-3 illustrate the value of confirming gene 
expression results at the functional level. However, for several clock proteins, 
the available commercial antibodies gave unsatisfactory western blots, and we 
could not confirm our qRT-PCR findings at the protein level. 
 
5.4 Association of a VNTR polymorphism in PER3 with 
chronotype 
It has been suggested that a main effect of the clock gene PER3 is to regulate 
sleep mechanisms (Archer, et al., 2008; Viola, et al., 2007; reviewed in Dijk 
and Archer, 2010), and a VNTR in PER3 has been proposed a role in 
determining chronotype (Archer, et al., 2003; Pereira, et al., 2005). The short 
PER3 allele has been associated with eveningness in healthy controls (Archer, 
et al., 2003; Pereira, et al., 2005; Lazar, et al., 2012) and in DSPD patients 
(Ebisawa, et al., 2001; Archer, et al., 2003) (Table 5.4). However, conflicting 
results have also been reported, such as an association between the long PER3 
allele and DSPD (Pereira, et al., 2005). Finally, several recent studies have 
reported no association between chronotype and the PER3 VNTR 
polymorphism in healthy controls (Viola, et al., 2007; Goel, et al., 2009; 
Barclay, et al., 2011) (Table 5.4). We performed a replication study in a sample 
of 432 Norwegian university students, but were not able to confirm previous 
findings of an association between the VNTR in PER3 and diurnal preference 
(paper III). 
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Table 5.4. Overview over association studies of the VNTR in PER3 and diurnal 
preference or DSPD. 
 
Reference Allele Association Tool for assessment 
of chronotype in 
healthy controls 
Geographic 
location 
(Ebisawa, et al., 2001) short DSPD not applicable Japan 
(Archer, et al., 2003) short 
short 
DSPD 
eveningness 
not applicable 
MEQ 
Great Britain 
(Pereira, et al., 2005) long 
long 
DSPD 
morningness 
not applicable 
MEQ 
Brazil 
(Viola, et al., 2007)  no association sleep-wake cycle, 
melatonin and cortisol 
rhythms 
Great Britain 
 
(Goel, et al., 2009)  no association Composite Scale U.S.A. 
(Viola, et al., 2011) long morningness activity, melatonin 
rhythm 
Switzerland 
and France 
(Barclay, et al., 2011)  no association MEQ Great Britain 
(Lazar, et al., 2012) long morningness MEQ and Munich 
Chronotype 
Questionnaire 
Ireland 
 
 
 
There may be several explanations for our negative finding. Chronotype has 
been shown to depend on age, where young adults are often associated with 
eveningness, and augmenting age is associated with increasing morningness 
(Carrier, et al., 1997; reviewed in Roenneberg, et al., 2007). In agreement with 
earlier studies (Archer, et al., 2003; Pereira, et al., 2005), a recent report 
demonstrated an association between the long allele and a phase advance of 
certain circadian parameters including melatonin in a sample of older people 
(Viola, et al., 2011). A limitation of our study was that the sample only 
consisted of young adults, which could have biased our results. However, the 
instrument scores for both questionnaires were normally distributed in our 
study population (paper III). Also, our sample had the advantage of being 
relatively homogeneous with respect to demographic variables such as age, 
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education and social environment, and although we did not specifically register 
the ethnic background of the participants, we estimated that the large majority 
of the volunteers were ethnically Norwegian. In support of this assumption, the 
observed genotype frequencies corresponded well with a previous report of 
PER3 VNTR genotypes on Norwegians (Nadkarni, et al., 2005). Another 
possible contributing factor could be the latitude of the geographic locations 
where the studies were performed, since the latitude varied markedly from 
study to study (Table 5.4) and many factors, such as temperature, daylight 
length and intensity vary greatly with latitude; hence it was proposed that 
latitude and ethnicity might have influenced the associations (Pereira, et al., 
2005). However, two studies found no evidence for natural selection of clock 
gene variants based on latitude (Nadkarni, et al., 2005; Ciarleglio, et al., 2008). 
It could also be that the role of PER3 is smaller than previously assumed, 
which is supported by a recent report on the VNTR in PER3 having no effect 
on circadian period (Hasan, et al., 2012), and the question of the role of PER3 
is left unanswered.  
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6  Concluding remarks and future perspectives 
We demonstrated that a main effect of lithium on clock gene expression was to 
differentially alter the oscillation amplitudes (paper I). Identifying molecular 
targets of lithium is highly valuable for understanding the pathophysiology 
underlying bipolar disorder and the molecular mechanisms of lithium action. 
Animal models of depression and mania may be useful to this purpose, and 
models of depression have long been established in rodents, such as the forced 
swim test (Porsolt, et al., 1978) and the tail suspension test (Steru, et al., 1985). 
Recently, novel animal models of bipolar mania have been proposed, including 
a model where disruption of the gene Clock causes behavior comparable to 
what is seen in manic patients (Roybal, et al., 2007). This is highly interesting 
in light of numerous studies demonstrating associations between 
polymorphisms in clock genes and bipolar disorder (Benedetti, et al., 2003; 
Nievergelt, et al., 2006; Kripke, et al., 2009). Although contradictory and 
negative findings have been reported (Mansour, et al., 2009; Kishi, et al., 
2009), recent efforts at the genome-wide level still support such an association 
(McCarthy, et al., 2012). Furthermore, based on studies linking bipolar 
disorder with the expression of the sodium pump Na+/K+-ATPase (NKA) in the 
brain, such as postmortem findings in brain tissue from patients (Rose, et al., 
1998) as well as association studies (Goldstein, et al., 2009), a novel model for 
mania was recently proposed, involving inactivation of neuron-specific NKA 
in mice (Kirshenbaum, et al., 2011). In line with the behavioral deficits in 
animal models of depression being lithium-sensitive (extensively reviewed in 
O'Donnell and Gould, 2007), lithium also rescued behavioral effects in both 
models of mania (Roybal, et al., 2007; Kirshenbaum, et al., 2011). In addition 
to elucidating the pathophysiology of bipolar disorder, such animal models 
open for the possibility to extensively monitor and manipulate parameters of 
the circadian clock, for further investigation of the action of lithium and other 
psychotropic drugs. 
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In addition to studying the effects of lithium on clock gene expression, we 
demonstrated that various psychotropic drugs with diverse pharmacological 
actions, including clozapine and imipramine, also influenced the levels of clock 
gene transcripts in NIH-3T3 cells, which could be relevant for their therapeutic 
effects (paper II). This is intriguing since the investigated drugs have main 
areas of use in distinct, although partly overlapping psychiatric illnesses 
(reviewed in Craddock, et al., 2006; Lin and Mitchell, 2008; Fountoulakis and 
Vieta, 2008). The various drugs had diverse effects, indicating that they act on 
the circadian clock via different mechanisms. However, they may have 
common targets relevant for their effects on circadian rhythms, and glycogen 
synthase kinase 3 (GSK-3) would be a good candidate, as antipsychotics, 
antidepressants and mood stabilizers have all been shown to regulate GSK-3 
(Sutton and Rushlow, 2011; Amar, et al., 2011; Park, et al., 2011; reviewed in 
Gould and Manji, 2005; Freyberg, et al., 2010), and since GSK-3 has been 
linked to the circadian clock (Iitaka, et al., 2005; Yin, et al., 2006). 
 
Obesity in the general population represents a major health issue, and even 
more so in psychiatric patients (McElroy, et al., 2002; Goldstein, et al., 2011; 
reviewed in Allison, et al., 2009), and metabolic side effects such as weight 
gain and dyslipidemia represent major concerns in drug-treatment (reviewed in 
Nasrallah, 2008; Lett, et al., 2011). We confirmed previous findings from our 
laboratory, demonstrating that antipsychotics and antidepressants increased the 
transcription of lipogenic genes in cell culture, which may have clinical 
relevance since these drugs are known to cause weight gain in the clinical 
setting (Berken, et al., 1984; Fernstrom, et al., 1986; Cohen, et al., 1990; 
Leadbetter, et al., 1992; reviewed in Allison, et al., 2009; Serretti and 
Mandelli, 2010), and the SREBP system has been implied in inducing marked 
weight gain in patients on antipsychotic drugs (Le Hellard, et al., 2009; 
reviewed in Ferno, et al., 2011). For clozapine and imipramine, we cannot rule 
out that the effects on clock genes are linked to their effects on lipid 
biosynthesis genes, even though our data does not clearly indicate this. 
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However, results from cell culture studies must be interpreted with caution, and 
animal studies and ultimately clinical trials are required to provide more 
definitive answers. Nevertheless, in vitro studies may provide useful clues for 
understanding the underlying mechanisms and may generate interesting leads 
to pursue further. Numerous clock genes and lipid metabolism genes have been 
proposed as possible mediators for the interplay between the circadian clock 
and lipid metabolism at the molecular level, including Per2, Bmal1, Rev-Erb-
, Ror-, Ppar- and Pgc-1 (Shimba, et al., 2005; Liu, et al., 2007; Le 
Martelot, et al., 2009; Grimaldi, et al., 2010; Schmutz, et al., 2010). To provide 
new insight into the underlying molecular mechanisms of the interaction, the 
technique of using small hairpin RNA (shRNA) to selectively knock down 
these genes could be very valuable (Paddison, et al., 2004; Sliva and Schnierle, 
2010). Correspondingly, exploring downstream effects after constitutively 
activating the expression of a given gene in vivo in animals and in vitro in cell 
culture could also provide new leads. 
 
The mechanisms by which the circadian clock influences sleep and diurnal 
preference, have been an increasing focus of attention (Leloup and Goldbeter, 
2008; for review, see von Schantz, 2008) since associations between sleep and 
a range of complications have been reported, including obesity and increased 
body mass index (Taheri, et al., 2004; Grandner, et al., 2011; Baron, et al., 
2011; reviewed in Knutson, et al., 2007; Oster, 2010) and psychiatric disorders 
(reviewed in Lamont, et al., 2010; Dallaspezia and Benedetti, 2011). 
Interestingly, it has been shown that bipolar patients are more likely to have a 
preference for evening compared to healthy controls (Mansour, et al., 2005; 
Giglio, et al., 2010). Of note, an association between evening chronotype and 
obesity in bipolar patients has also been reported (Soreca, et al., 2009). Taken 
together, these findings further highlight the close relationship between the 
circadian clock, bipolar disorder and lipid metabolism. We studied the impact 
of the clock gene PER3 in influencing diurnal preference in healthy students, 
but could not confirm a significant association between the VNTR 
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polymorphism in PER3 and self-report measures of the morningness-
eveningness dimension in our study sample (paper III). It seems improbable 
that a single genetic variant in one gene should be responsible for determining 
chronotype, and in fact, it has been proposed that several clock genes could 
each make minor contributions to determining chronotype, whereas specific 
combinations of these polymorphisms are required to produce a significant 
association (Pedrazzoli, et al., 2010). In agreement with this, a recent study 
found relevant effects of several polymorphisms in clock genes on chronotype 
and adaptation to shift-work (Gamble, et al., 2011). Hence, in future 
association studies, it would be interesting to explore the effects of 
combinations of multiple variants on diurnal preference. Of note, the same 
mechanism might in part explain the hidden heritability of bipolar disorder. It 
has been suggested that multiple genetic variants could each make minor 
contributions towards disease vulnerability, which taken together might 
represent a substantial risk for bipolar disorder (reviewed in Gershon, et al., 
2011). Hence, also here it could be interesting to explore the synergy of several 
genes in conferring risk for bipolar disorder.  
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